FOR THE IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS WITH CANCER THERAPY
摘要
The present invention is directed to the identification of predictive markers that can be used to determine whether patients with cancer are expected to demonstrate long term or short term survival times. In particular, the present invention is directed to the use of certain individual and/or combinations of predictive markers, wherein the expression of the predictive markers correlates with expected short term or long term survival. Thus, by examining the expression levels of individual predictive markers and/or predictive markers comprising a marker set, it is possible to determine predicted patient survival.
申请公布号
WO2008021183(A9)
申请公布日期
2008.07.24
申请号
WO2007US17716
申请日期
2007.08.09
申请人
MILLENNIUM PHARMACEUTICALS, INC.;BRYANT, BARBARA, M.;DAMOKOSH, ANDREW, I.;MULLIGAN, GEORGE
发明人
BRYANT, BARBARA, M.;DAMOKOSH, ANDREW, I.;MULLIGAN, GEORGE